Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JENNIFER LYNN NASH

Allopathic & Osteopathic Physicians Dermatology

NPI
1518924299
CMS profile
341673
Location
WESTERVILLE, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$469.87

19 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $469.87 19

By paying entity

PY2020 · entire year · sorted by reported total

Page 1 of 1; records 1–19 of 19 matching records. This page contains 19 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JENNIFER LYNN NASH

NPI 1518924299 · CMS profile ID 341673

Allopathic & Osteopathic Physicians / Dermatology

WESTERVILLE, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–19 of 19 matching records. This page contains 19 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1518924299?year=2020&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JENNIFER LYNN NASH, NPI 1518924299, CMS profile ID 341673. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–19 of 19 matching records. This page contains 19 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1518924299?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). JENNIFER LYNN NASH, NPI 1518924299, CMS profile ID 341673. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–19 of 19 matching records. This page contains 19 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1518924299?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
JENNIFER LYNN NASH, NPI 1518924299, CMS profile ID 341673, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–19 of 19 matching records. This page contains 19 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1518924299?year=2020&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

19 matching records · $469.87 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 19 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–19 of 19.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AbbVie Inc. $18.5812/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722049537 CMS
Lilly USA, LLC $15.1111/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728480691 CMS
Galderma Laboratories, L.P. $13.8209/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726871221 CMS
Lilly USA, LLC $17.9209/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728480689 CMS
AbbVie Inc. $16.7209/01/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722049535 CMS
AbbVie Inc. $15.9208/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722049533 CMS
AbbVie Inc. $15.4907/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722049531 CMS
Lilly USA, LLC $17.8507/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728473857 CMS
AbbVie Inc. $14.8507/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722049529 CMS
AbbVie Inc. $15.9206/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722049527 CMS
Galderma Laboratories, L.P. $11.5303/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726871219 CMS
MERZ NORTH AMERICA, INC. $200.0003/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 737053685 CMS
Galderma Laboratories, L.P. $13.5203/03/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726871217 CMS
PFIZER INC. $13.3603/02/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743093863 CMS
MERZ NORTH AMERICA, INC. $11.5102/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 737049047 CMS
Ortho Dermatologics, a division of Bausch Health US, LLC $13.8902/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 737470053 CMS
Novartis Pharmaceuticals Corporation $18.4802/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726040355 CMS
Regeneron Healthcare Solutions, Inc. $12.8101/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 724441923 CMS
Lilly USA, LLC $12.5901/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728477195 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $805.11 23
PY2020 $469.87 19
PY2021 $826.06 49
PY2022 $940.34 56
PY2023 $1,456.33 76
PY2024 $1,893.47 104
PY2025 $1,665.20 83

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $243,014.48 48
PY2024 Recipient $1,267.72 7
PY2024 Principal investigator $137,527.38 8
PY2023 Principal investigator $787,642.30 65
PY2022 Recipient $187.10 4
PY2022 Principal investigator $974,316.67 62
PY2021 Recipient $890.12 6
PY2021 Principal investigator $503,922.68 30
PY2020 Principal investigator $730,035.42 59
PY2019 Principal investigator $647,335.59 32

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

59 records in PY2020

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Allergan, Inc. $6,033.96 12/31/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal GL Only - US/EU No dispute reported 06/30/2026 721317987
Principal investigator 1 Allergan, Inc. $7,244.31 12/31/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal LCL and GL+ LCL - US/EU No dispute reported 06/30/2026 721318003
Principal investigator 1 Allergan, Inc. $700.00 12/29/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
GLABELLAR LINES ONLY No dispute reported 06/30/2026 721314137
Principal investigator 1 Allergan, Inc. $24,853.75 12/15/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Open-label Extension Study No dispute reported 06/30/2026 721313263
Principal investigator 1 Allergan, Inc. $1,539.00 12/15/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal GL Only - US/EU No dispute reported 06/30/2026 721313301
Principal investigator 1 Allergan, Inc. $8,702.00 12/15/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal LCL and GL+ LCL - US/EU No dispute reported 06/30/2026 721313305
Principal investigator 1 Allergan, Inc. $327.00 12/03/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
GLABELLAR LINES ONLY No dispute reported 06/30/2026 721310431
Principal investigator 1 Allergan, Inc. $327.00 12/03/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
PH 3 PIVOTAL LCL AND GL AND LCL - US/EU No dispute reported 06/30/2026 721310583
Principal investigator 1 Allergan, Inc. $700.00 11/17/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
PH 3 PIVOTAL LCL AND GL AND LCL - US/EU No dispute reported 06/30/2026 721308419
Principal investigator 1 Allergan, Inc. $34,660.75 11/17/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Open-label Extension Study No dispute reported 06/30/2026 721308619
Principal investigator 1 Allergan, Inc. $6,840.00 11/13/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal GL Only - US/EU No dispute reported 06/30/2026 721307875
Principal investigator 1 Allergan, Inc. $9,984.50 11/13/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal LCL and GL+ LCL - US/EU No dispute reported 06/30/2026 721307879
Principal investigator 1 Allergan, Inc. $327.00 11/05/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
PH 3 OPEN-LABEL EXTENSION No dispute reported 06/30/2026 721306759
Principal investigator 1 Allergan, Inc. $5,244.00 10/20/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal GL Only - US/EU No dispute reported 06/30/2026 721304487
Principal investigator 1 Allergan, Inc. $11,020.00 10/20/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal LCL and GL+ LCL - US/EU No dispute reported 06/30/2026 721304491
Principal investigator 1 Allergan, Inc. $24,486.25 10/14/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Open-label Extension Study No dispute reported 06/30/2026 721302689
Principal investigator 1 Allergan, Inc. $327.00 10/01/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
PH 3 PIVOTAL LCL AND GL AND LCL - US/EU No dispute reported 06/30/2026 721301087
Principal investigator 1 Allergan, Inc. $327.00 10/01/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
GLABELLAR LINES ONLY No dispute reported 06/30/2026 721301195
Principal investigator 1 Allergan, Inc. $10,317.00 09/24/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal GL Only - US/EU No dispute reported 06/30/2026 721300531
Principal investigator 1 Allergan, Inc. $15,342.50 09/22/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal LCL and GL+ LCL - US/EU No dispute reported 06/30/2026 721300051
Principal investigator 1 Allergan, Inc. $29,768.25 09/15/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Open-label Extension Study No dispute reported 06/30/2026 721297783
Principal investigator 1 Allergan, Inc. $8,037.00 09/03/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal GL Only - US/EU No dispute reported 06/30/2026 721295501
Principal investigator 1 Allergan, Inc. $11,808.50 09/03/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal LCL and GL+ LCL - US/EU No dispute reported 06/30/2026 721295507
Principal investigator 1 Allergan, Inc. $327.00 09/01/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
PH 3 OPEN-LABEL EXTENSION No dispute reported 06/30/2026 721294613
Principal investigator 1 Allergan, Inc. $700.00 08/27/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
PH 3 OPEN-LABEL EXTENSION No dispute reported 06/30/2026 721293489
Principal investigator 1 Allergan, Inc. $33,782.00 08/17/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Open-label Extension Study No dispute reported 06/30/2026 721290653
Principal investigator 1 Allergan, Inc. $6,498.00 07/20/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal GL Only - US/EU No dispute reported 06/30/2026 721285611
Principal investigator 1 Allergan, Inc. $22,629.00 07/20/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal LCL and GL+ LCL - US/EU No dispute reported 06/30/2026 721285613
Principal investigator 1 Allergan, Inc. $600.00 07/20/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal LCL and GL+ LCL - US/EU No dispute reported 06/30/2026 721285633
Principal investigator 1 Allergan, Inc. $31,430.75 07/15/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Open-label Extension Study No dispute reported 06/30/2026 721284481
Principal investigator 1 Allergan, Inc. $14,924.50 06/19/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal LCL and GL+ LCL - US/EU No dispute reported 06/30/2026 721280993
Principal investigator 1 Allergan, Inc. $7,467.00 06/18/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal GL Only - US/EU No dispute reported 06/30/2026 721280883
Principal investigator 1 Allergan, Inc. $28,462.00 06/16/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Open-label Extension Study No dispute reported 06/30/2026 721280403
Principal investigator 1 Allergan, Inc. $654.00 06/11/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
PH 3 PIVOTAL LCL AND GL AND LCL - US/EU No dispute reported 06/30/2026 721279119
Principal investigator 1 Allergan, Inc. $13,147.20 06/03/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal GL Only - US/EU No dispute reported 06/30/2026 721278589
Principal investigator 1 Allergan, Inc. $20,395.20 06/03/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal LCL and GL+ LCL - US/EU No dispute reported 06/30/2026 721278593
Principal investigator 1 Allergan, Inc. $10,293.25 05/28/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Open-label Extension Study No dispute reported 06/30/2026 721277857
Principal investigator 1 Allergan, Inc. $9,006.00 05/15/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal GL Only - US/EU No dispute reported 06/30/2026 721275513
Principal investigator 1 Allergan, Inc. $21,736.00 05/15/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal LCL and GL+ LCL - US/EU No dispute reported 06/30/2026 721275519
Principal investigator 1 Allergan, Inc. $40,237.25 04/24/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Open-label Extension Study No dispute reported 06/30/2026 721272747
Principal investigator 1 Allergan, Inc. $9,234.00 04/22/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal GL Only - US/EU No dispute reported 06/30/2026 721272045
Principal investigator 1 Allergan, Inc. $7,695.00 04/22/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal LCL and GL+ LCL - US/EU No dispute reported 06/30/2026 721272059
Principal investigator 1 Allergan, Inc. $6,000.00 04/07/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Open-label Extension Study No dispute reported 06/30/2026 721269137
Principal investigator 1 Allergan, Inc. $750.00 04/07/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Open-label Extension Study No dispute reported 06/30/2026 721269139
Principal investigator 1 Allergan, Inc. $29,131.75 04/06/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Open-label Extension Study No dispute reported 06/30/2026 721268935
Principal investigator 1 Allergan, Inc. $50.00 04/01/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal LCL and GL+ LCL - US/EU No dispute reported 06/30/2026 721268455
Principal investigator 1 Allergan, Inc. $14,535.00 03/23/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal GL Only - US/EU No dispute reported 06/30/2026 721266547
Principal investigator 1 Allergan, Inc. $21,128.00 03/23/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal LCL and GL+ LCL - US/EU No dispute reported 06/30/2026 721266553
Principal investigator 1 Allergan, Inc. $25,840.00 03/04/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Open-label Extension Study No dispute reported 06/30/2026 721261969
Principal investigator 1 Allergan, Inc. $4,916.25 03/04/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Open-label Extension Study No dispute reported 06/30/2026 721261977
Principal investigator 1 Allergan, Inc. $37,392.00 02/24/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal GL Only - US/EU No dispute reported 06/30/2026 721259637
Principal investigator 1 Allergan, Inc. $28,918.00 02/24/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal LCL and GL+ LCL - US/EU No dispute reported 06/30/2026 721259643
Principal investigator 1 Allergan, Inc. $86.00 02/18/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
PH 3 PIVOTAL LCL AND GL AND LCL - US/EU No dispute reported 06/30/2026 721258211
Principal investigator 1 Allergan, Inc. $700.00 02/04/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
GLABELLAR LINES ONLY No dispute reported 06/30/2026 721255293
Principal investigator 1 Allergan, Inc. $327.00 02/04/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
PH 3 OPEN-LABEL EXTENSION No dispute reported 06/30/2026 721255799
Principal investigator 1 Allergan, Inc. $22,800.00 01/21/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal GL Only - US/EU No dispute reported 06/30/2026 721249557
Principal investigator 1 Allergan, Inc. $38,940.50 01/21/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal LCL and GL+ LCL - US/EU No dispute reported 06/30/2026 721249563
Principal investigator 1 Allergan, Inc. $86.00 01/16/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
PH 3 PIVOTAL LCL AND GL AND LCL - US/EU No dispute reported 06/30/2026 721248197
Principal investigator 1 Allergan, Inc. $300.00 01/01/2020 Non-covered Recipient Entity
AVENTIV RESEARCH
Ph 3 Pivotal GL Only - US/EU No dispute reported 06/30/2026 721245103